Summit Therapeutics Stock Options
| SMMT Stock | USD 18.79 0.82 4.56% |
Summit Therapeutics' latest option contracts expiring on 2024-12-13 are carrying combined implied volatility of 0.83 with a put-to-call open interest ratio of 0.0 over 24 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-12-13. The total put volume is at 46.0, with calls trading at the volume of 46.0. This yields a 0.35 put-to-call volume ratio.
In The Money vs. Out of Money Option Contracts on Summit Therapeutics
Analyzing Summit Therapeutics' in-the-money options over time can help investors to take a profitable long position in Summit Therapeutics regardless of its overall volatility. This is especially true when Summit Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Summit Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Summit Therapeutics' stock while costing only a fraction of its price.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Summit Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Summit Therapeutics PLC In The Money Call Balance
When Summit Therapeutics' strike price is surpassing the current stock price, the option contract against Summit Therapeutics PLC stock is said to be in the money. When it comes to buying Summit Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Summit Therapeutics PLC are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Summit Current Options Market Mood
Summit Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Summit Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Summit Therapeutics' options investors are not very successful. Summit Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Summit contract
Base on the Rule 16, the options market is currently suggesting that Summit Therapeutics PLC will have an average daily up or down price movement of about 0.0519% per day over the life of the 2024-12-13 option contract. With Summit Therapeutics trading at USD 18.79, that is roughly USD 0.009747. If you think that the market is fully incorporating Summit Therapeutics' daily price movement you should consider buying Summit Therapeutics PLC options at the current volatility level of 0.83%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Summit |
Purchasing Summit Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Summit calls. Remember, the seller must deliver Summit Therapeutics PLC stock to the call owner when a call is exercised.
Summit Therapeutics Option Chain
When Summit Therapeutics' strike price is surpassing the current stock price, the option contract against Summit Therapeutics PLC stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2024-12-132024-12-202024-12-272025-01-032025-01-102025-01-172025-01-242025-04-172025-07-182025-09-192025-12-192026-01-162027-01-15
Summit Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Summit. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Summit. It also shows strike prices and maturity days for a Summit Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | SMMT Option Call 13-12-2024 14 | 0 | 2024-12-13 | 2.85 - 7.0 | 4.53 | In |
Call | SMMT Option Call 13-12-2024 14 | 0 | 2024-12-13 | 3.2 - 6.1 | 4.1 | In |
Call | SMMT Option Call 13-12-2024 15 | 0 | 2024-12-13 | 0.0 - 0.0 | 4.5 | In |
Call | SMMT Option Call 13-12-2024 17 | 0 | 2024-12-13 | 0.0 - 0.0 | 1.98 | In |
Call | SMMT Option Call 13-12-2024 18 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.55 | |
Call | SMMT Option Call 13-12-2024 18 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.8 | |
Call | SMMT Option Call 13-12-2024 19 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.14 | |
Call | SMMT Option Call 13-12-2024 19 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.33 | |
Call | SMMT Option Call 13-12-2024 20 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.05 | |
Call | SMMT Option Call 13-12-2024 20 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.38 | |
Call | SMMT Option Call 13-12-2024 21 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.08 | |
Call | SMMT Option Call 13-12-2024 21 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.1 | |
Call | SMMT Option Call 13-12-2024 23 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.05 | |
Call | SMMT Option Call 13-12-2024 23 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.1 | |
Call | SMMT Option Call 13-12-2024 24 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.1 | |
Call | SMMT Option Call 13-12-2024 25 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.35 | |
Put | SMMT Option Put 13-12-2024 16 | 2 | 2024-12-13 | 0.0 - 0.55 | 0.85 | Out |
Put | SMMT Option Put 13-12-2024 17 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.1 | |
Put | SMMT Option Put 13-12-2024 17 | 0 | 2024-12-13 | 0.0 - 0.0 | 1.0 | |
Put | SMMT Option Put 13-12-2024 18 | 0 | 2024-12-13 | 0.0 - 0.0 | 1.04 | In |
Put | SMMT Option Put 13-12-2024 18 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.5 | In |
Put | SMMT Option Put 13-12-2024 19 | 0 | 2024-12-13 | 0.0 - 0.0 | 1.18 | In |
Put | SMMT Option Put 13-12-2024 20 | 0 | 2024-12-13 | 0.0 - 0.0 | 1.7 | In |
Put | SMMT Option Put 13-12-2024 22 | 2 | 2024-12-13 | 2.0 - 6.5 | 4.2 | In |
Summit Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Summit Total Stockholder Equity
Total Stockholder Equity |
|
Summit Therapeutics Corporate Management
| Elaine JD | Head Counsel | Profile | |
| Fong Clow | Chief Officer | Profile | |
| Betty Chang | Oncology Research | Profile | |
| Bhaskar Anand | Chief Finance | Profile | |
| Will Black | Head Technology | Profile |
Additional Tools for Summit Stock Analysis
When running Summit Therapeutics' price analysis, check to measure Summit Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Summit Therapeutics is operating at the current time. Most of Summit Therapeutics' value examination focuses on studying past and present price action to predict the probability of Summit Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Summit Therapeutics' price. Additionally, you may evaluate how the addition of Summit Therapeutics to your portfolios can decrease your overall portfolio volatility.